CD57+ expression in T lymphocytes has beenrecognized as a marker of in vitro replicative senescence and offunctional immune deficiency in patients with autoimmune disease, infectiousdiseases, and cancers (reviewed in Focosi et al. (24)). The gene discussed is B3GAT1; the disease is cancer.